Product Information
METHYLERGONOVINE 0.2 MG TABLET is a generic product labeled by American Health Packaging, priced at $4.4972 per EA under NDC 60687081394. Its NADAC has been published 130 times since Apr 10, 2024.
FDA first approved this application on May 15, 2018. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
.2 mg/1
Manufacturer
American Health PackagingNDC
60687081394
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
METHYLERGONOVINE MALEATEApproval Type
Generic (ANDA)
FDA Application
ANDA210424FDA Approved
5/15/2018
TE Code
AB
On Market Since
2/15/2024
Pharmacological Classes
Price Statistics
The NADAC for METHYLERGONOVINE 0.2 MG TABLET has been published 130 times since Apr 10, 2024, and over the history we have for it it has declined 41.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $4.4972 per EA |
|---|---|
| All-time high | $8.4450 (Dec 11, 2024) |
| All-time low | $4.3506 (Aug 19, 2026) |
| 52-week high | $5.7474 |
| 52-week low | $4.3506 |
| Median price | $5.9822 |
| Average price | $6.0043 |
| Largest weekly change | -18.7% (Apr 17, 2024) |
| Weeks tracked | 130 |
| Tracking since | Apr 10, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
American Health Packaging manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Methylergonovine Maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Ergot Derivative class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of METHYLERGONOVINE 0.2 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for METHYLERGONOVINE 0.2 MG TABLET, manufactured by American Health Packaging, is $4.4972 per EA (NDC 60687081394), effective Sep 30, 2026.
How has the price of METHYLERGONOVINE 0.2 MG TABLET changed over time?
Over the history we have for it, the NADAC for METHYLERGONOVINE 0.2 MG TABLET has declined 41.6%. It has been tracked across 130 weekly CMS publications since Apr 10, 2024.
What are the highest and lowest recorded NADAC prices for METHYLERGONOVINE 0.2 MG TABLET?
Since Apr 10, 2024, the NADAC for METHYLERGONOVINE 0.2 MG TABLET has ranged from a low of $4.3506 (Aug 19, 2026) to a high of $8.4450 (Dec 11, 2024), with a median of $5.9822 per EA.
Are there cheaper alternatives to METHYLERGONOVINE 0.2 MG TABLET?
4 manufacturers publish a NADAC-priced product with the same active ingredient and strength as METHYLERGONOVINE 0.2 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures METHYLERGONOVINE 0.2 MG TABLET?
METHYLERGONOVINE 0.2 MG TABLET (NDC 60687081394) is labeled by American Health Packaging, and CMS classifies it as a generic product.